Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06426355
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2024-03-17
Brief Title:
The Effeciency of NMN in Improving IVFICSI-ET Pregnancy Outcomes in Patients With DOR
Sponsor:
Peking University Third Hospital
Organization:
Peking University Third Hospital
Study Overview
Official Title:
The Effeciency of Nicotinamide Mononucleotide NMN in Improving IVFICSI-ET Pregnancy Outcomes in Patients With Decreased Ovarian ReserveDOR a Randomized Double-blind Placebo Control Clinical Trail
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to understand the effect of nicotinamide mononucleotide NMN on patients with diminished ovarian reserve and the outcomes of IVFICSI-ET
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None